Brief Report: Childhood‐Onset Systemic Necrotizing Vasculitides: Long‐Term Data From the French Vasculitis Study Group Registry
暂无分享,去创建一个
E. Daugas | L. Mouthon | A. Aouba | P. Quartier | M. Büchler | J. Serratrice | X. Puéchal | L. Guillevin | C. Agard | B. Terrier | C. Pagnoux | P. Guilpain | P. Cohen | C. de Moreuil | R. Cevallos | C. Bachmeyer | A. le Quellec | P. Roblot | M. Iudici
[1] M. Matucci-Cerinic,et al. Clinical overview and outcome in a cohort of children with polyarteritis nodosa. , 2014, Clinical and experimental rheumatology.
[2] N. Klein,et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. , 2013, Arthritis and rheumatism.
[3] S. Spalding,et al. Childhood-onset Eosinophilic Granulomatosis with Polyangiitis (formerly Churg-Strauss Syndrome): A Contemporary Single-center Cohort , 2013, The Journal of Rheumatology.
[4] S. Özen,et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS) , 2012, Annals of the rheumatic diseases.
[5] P. Merkel,et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.
[6] A. Bakkaloğlu,et al. EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.
[7] A. Reiff,et al. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. , 2009, Arthritis and rheumatism.
[8] J. Zwerina,et al. Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. , 2009, Seminars in arthritis and rheumatism.
[9] R. Schneider,et al. Clinical features and outcome of pediatric Wegener's granulomatosis. , 2007, Arthritis and rheumatism.
[10] H. Raspe,et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis , 2006, Annals of the rheumatic diseases.
[11] W. Kuis,et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. , 2004, The Journal of pediatrics.
[12] V. Shah,et al. Clinical features in 17 paediatric patients with Wegener granulomatosis , 2002, Pediatric Nephrology.
[13] S. Ozen,et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa , 2001, Archives of disease in childhood.
[14] M. Hattori,et al. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. , 2001, Journal of the American Society of Nephrology : JASN.
[15] B. Malmer,et al. Wegener granulomatosis in children and young adults. A case study of ten patients. , 2000, Pediatric nephrology.
[16] C. Gordon,et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. , 1997, Arthritis and rheumatism.
[17] R. Moots,et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.
[18] Guy Hoffman,et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. , 1993, The Journal of pediatrics.
[19] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.